Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
444.77
+1.61 (+0.36%)
Streaming Delayed Price
Updated: 12:06 PM EDT, Mar 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
72
73
Next >
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
↗
May 03, 2024
Discover three under-the-radar pharma stocks poised for significant growth in 2024. Explore their product pipelines and potential gains.
Via
InvestorPlace
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
↗
May 02, 2024
Via
Benzinga
2 Top Growth Stocks to Buy Right Now and Hold Forever
↗
April 28, 2024
These healthcare stocks can provide enviable long-term portfolio growth.
Via
The Motley Fool
Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades.
↗
April 27, 2024
These three should have a lot of room to run.
Via
The Motley Fool
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
↗
April 26, 2024
Unlock Vertex Pharmaceuticals' pioneering treatments, from the groundbreaking Trikafta for cystic fibrosis to the promising non-opioid painkillers.
Via
Benzinga
(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest
↗
April 25, 2024
Via
Benzinga
2 Fantastic Growth Stocks to Buy Right Now
↗
April 25, 2024
Don't overlook these high-growth businesses.
Via
The Motley Fool
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $6,000 Today
↗
April 16, 2024
Via
Benzinga
The Analyst Landscape: 16 Takes On Vertex Pharmaceuticals
↗
April 12, 2024
Via
Benzinga
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
↗
April 24, 2024
Good news could be just around the corner for two drugmakers not named Novo Nordisk.
Via
The Motley Fool
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
↗
April 23, 2024
Vertex is broadening its portfolio.
Via
The Motley Fool
Making Sense of Amazon CEO Andy Jassy's Latest Letter
↗
April 22, 2024
And that's just part of the interesting news for investors to dig into.
Via
The Motley Fool
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
↗
April 22, 2024
Could Vertex's growth story continue?
Via
The Motley Fool
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now
↗
April 22, 2024
These stocks could be near major inflection points.
Via
The Motley Fool
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
↗
April 20, 2024
These stocks probably won't be getting much cheaper.
Via
The Motley Fool
3 Relatively Safe Growth Stocks You Can Buy and Hold
↗
April 20, 2024
Low risk and high-reward potential? These stocks could offer both.
Via
The Motley Fool
3 Biotech Stocks Set to Double by 2028
↗
April 20, 2024
These are three of the top biotech stocks set to double by 2028. Add them to your portfolio to maximize your potential gains.
Via
InvestorPlace
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
↗
April 19, 2024
Does this pharma stock have the potential to turn a $25,000 investment into seven figures or more?
Via
The Motley Fool
Tesla To $123? Here Are 10 Top Analyst Forecasts For Thursday
↗
April 18, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
↗
April 18, 2024
The biotech just added another potential growth driver to its pipeline.
Via
The Motley Fool
Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
April 18, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
↗
April 15, 2024
Vertex just laid claim to an asset that might be very valuable.
Via
The Motley Fool
Could This Stock Be the Next Biotech Buyout?
↗
April 13, 2024
Vertex Pharmaceuticals' $4.9 billion purchase of Alpine Immune Sciences probably won't be the last acquisition of a company focused on kidney disease.
Via
The Motley Fool
Stock Market Sends Mixed Signals; Nvidia, Inflation, Mideast Fears In Focus: Weekly Review
↗
April 12, 2024
The stock market gave some bullish signs, with Nvidia rebounding, but the indexes generally fell for the week on inflation and Mideast fears.
Via
Investor's Business Daily
Topics
Economy
Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact
↗
April 11, 2024
Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-mediated kidney disease treatments. Analysts foresee significant revenue growth...
Via
Benzinga
Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?
↗
April 11, 2024
Investors can breathe a sigh of relief on Thursday as last month’s Producer Price Index (PPI) inflation turned out slightly lower than expected, albeit with some caveats across different measures...
Via
Benzinga
Topics
Economy
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
↗
April 11, 2024
In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.
Via
InvestorPlace
Raymond James Just Raised Its Price Target on Nvidia (NVDA) Stock
↗
April 11, 2024
Nvidia stock is on the move Thursday after shares of NVDA got an increased price target of $1,100 from Raymond James analysts.
Via
InvestorPlace
Apple Spyware Warning: What to Know About ‘Mercenary Spyware Attack’ Alerts
↗
April 11, 2024
An Apple spyware warning has been sent to iPhone owners in 92 states as they have been targeted by a mercenary spyware attack.
Via
InvestorPlace
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
↗
April 11, 2024
Vertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.
Via
InvestorPlace
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
72
73
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
